Biorad Medisys: Financial Breakdown
Decoding financial health metrics of Biorad Medisys
Total Revenue₹342.6 Cr+48%Prev. FY
Total Expenses₹269.1 Cr+44%Prev. FY
Profit After Tax₹53.0 Cr+66%Prev. FY
Total Assets₹521.2 Cr+42%Prev. FY
Net Profit Margin0.1%7%Prev. FY
FAQs on Financials of Biorad Medisys
Yes. In FY24, Biorad Medisys reported a profit after tax of ₹53.0 Cr+, making it profitable.
Biorad Medisys's revenue grew 48.5% year-on-year, from ₹230.8 Cr+ in FY23 to ₹342.6 Cr+ in FY24.
Biorad Medisys's estimated EBITDA for FY24 was ₹110.7 Cr+, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY24, Biorad Medisys posted revenue of ₹342.6 Cr+ (up 48.5% YoY) and a profit after tax of ₹53.0 Cr+. Explore the full financials of Biorad Medisys here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links